Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,497 public trials 2,844 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets

NCT05308654

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Stanford University School of Med /ID# 242809 Stanford, California, United States
  • Sylvester Comprehensive Cancer Center /ID# 243417 Miami, Florida, United States
  • Tulane University School of Medicine /ID# 244854 New Orleans, Louisiana, United States
  • American Oncology Partners of Maryland /ID# 244858 Bethesda, Maryland, United States
View all 21 locations
View Trial Details
Active, not recruiting

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

NCT04086264

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • City of Hope National Medical Center /ID# 269273 Duarte, California, United States
  • University Of California Irvine Medical Center /ID# 269275 Orange, California, United States
  • Moffitt Cancer Center /ID# 269269 Tampa, Florida, United States
  • Northwestern University- Robert H. Lurie Comprehensive Cancer Center /ID# 269642 Chicago, Illinois, United States
View all 29 locations
View Trial Details
Active, not recruiting

A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV

NCT05481151

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • Baptist MD Anderson Jacksonville, Florida, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • University of Kansas Medical Center Westwood, Kansas, United States
  • Mercy Health Paducah, Kentucky, United States
View all 23 locations
View Trial Details
Active, not recruiting

A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET

NCT05482971

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Marin Cancer Care Greenbrae, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 34 locations
View Trial Details
Active, not recruiting

A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.

NCT05567458

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Local Institution - 0002 Maoming, Guangdong, China
  • Local Institution - 0005 Shenzhen, Guangdong, China
  • Local Institution - 0007 Liuzhou, Guangxi, China
  • Local Institution - 0003 Nanning, GX, China
View Trial Details
Active, not recruiting

Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China

NCT05144243

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Peking Union Medical College Hospital (East) - Dongdan Campus /ID# 233179 Beijing, Beijing Municipality, China
  • Peking University International Hospital /ID# 232254 Beijing, Beijing Municipality, China
  • Sun Yat-Sen University Cancer Center /ID# 231793 Guangzhou, Guangdong, China
  • Zhujiang Hospital of Southern Medical University /ID# 231792 Guangzhou, Guangdong, China
View all 18 locations
View Trial Details

Related conditions